Synopsys said this Form 8-K/A (Amendment No. 1) amends the Original 8-K filed on July 17, 2025 to update the disclosure under Item 5.02. The company explained the amendment includes additional disclosure regarding Mr. Vijayaraghavan's appointment to a committee of the Board.

1. 01

   Synopsys said this Form 8-K/A (Amendment No. 1) amends the Original 8-K filed on July 17, 2025 to update the disclosure under Item 5.02. The company explained the amendment includes additional disclosure regarding Mr. Vijayaraghavan's appointment to a committee of the Board.

2. 02

   Synopsys disclosed that on September 17, 2025 the Board appointed Mr. Vijayaraghavan as a member of the Corporate Governance and Nominating Committee.

3. 03

   As previously reported in the Original 8-K, Synopsys said the Board appointed Mr. Vijayaraghavan as a member of the Board on July 17, 2025.

4. 04

   Synopsys said no other changes are being made to the Original 8-K in this amendment. The amendment was signed on September 18, 2025 by Janet Lee, General Counsel and Corporate Secretary.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.